|Day Low/High||113.91 / 114.95|
|52 Wk Low/High||101.42 / 142.50|
Although the buying power was a welcome relief, the wide index ranges haven't set up good bases.
A financial stock play on taxi cabs, several stock picks under $10 and more.
How the market reacts to Tuesday's producer price index number should help clear things up.
Today's market action offered little good news as breadth was awful and stocks gave back their recent gains.
Despite a try at a bottom, the market is still oversold, but oil's crushing move to the downside was the real news.
Few barriers seem to exist between the current levels and the November lows.
The calls here should once again reward investors. Plus, another look at the Stat Book.
Cramer said that the stock's risk/reward is 'a thing of beauty.'
Its reaction to recent troubles bodes well for the options.
Expectations are low, helping the market rise above them. But NYSE floor trader Peter Costa says enthusiasm is missing.
Shares are greased up after the company puts first-quarter earnings well ahead of views.
Boston Sci's expected stent-sales shortfall should make St. Jude a cheaper play.
Even though EA has the wildly popular Madden NFL game, GameStop is better positioned, says Cramer.
Cramer says Merck, Pfizer and Schering-Plough are all better than Barr Pharma.
The week's highlights from the site's five bloggers: Jim Cramer, Rev Shark, Cody Willard, Steve Smith and Tony Crescenzi.
Cramer goes against the herd when it comes to playing the market after a terrorist threat.
Cramer says stocks are resilient to the news of a foiled terrorist plot.
Cramer says you still need to stay away from stocks that have exposure to the economy.
Cramer sees a merger with Varian, an oncology radiation company.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.